// App-Quantinova.ai

S109 : ONCOGENIC DEUBIQUITINATION CONTROLS TYROSINE KINASE SIGNALING AND THERAPY RESPONSE IN ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Panagiotis Ntziachristos

Principal Investigators

  • Qi Jin

Medical Centers

  • MD Anderson,Houston,Vereinigte Staaten

  • Ghent University,Ghent,België

  • Pathology,Northwestern University,Chicago,Verenigde Staten

  • Ghent University Hospital, Ghent, Belgium

  • Ghent University,Ghent,België

  • MD Anderson,Houston,Stati Uniti

  • Northwestern University...

  • Rush University Medical Center, Chicago, Illinois, United States

  • VIB Ghent University, Ghent, Belgium

  • Ghent University,Ghent,België

  • MD Anderson,Houston,États-unis

  • MD Anderson, Houston, TX, USA

  • Pathology,Northwestern University,Chicago,Verenigde Staten

  • MD Anderson,Houston,Estados Unidos

  • Northwestern University,Chicago,États-unis

  • M.D. Anderson, Houston, Texas, United States

  • Northwestern University,Chicago,États-unis

  • Northwestern University,Chicago,Estados Unidos

  • MD Anderson,Houston,Vereinigte Staaten

  • Ghent University,Ghent,België

Locations

  • Belgium

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved